PWM
NVIV

Paulson Wealth Management’s InVivo Therapeutics Holdings Corp NVIV Stock Holding History

Paulson Wealth Management’s Portfolio NVIV Stock Details NVIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-15
Closed -$6K – 117
2019
Q3 		$6K Hold
15
– – ﹤0.01% 108
2019
Q2 		$7K Hold
15
– – 0.01% 106
2019
Q1 		$17K Hold
15
– – 0.01% 114
2018
Q4 		$4K Hold
15
– – ﹤0.01% 115
2018
Q3 		$3K Hold
15
– – ﹤0.01% 125
2018
Q2 		$4K Buy
+15
New +$82.3K ﹤0.01% 113
2018
Q1 		– Sell
-1
Closed -$9K – 610
2017
Q4 		$9K Buy
+1
New +$23.1K 0.01% 387

Other funds holding NVIV

PCM
Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
ICM
IMS Capital Management Portland, Oregon $217M AUM 18.69% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Paulson Wealth Management's NVIV Position: Q4 2019 in Review

Paulson Wealth Management sold out of InVivo Therapeutics Holdings Corp (NVIV) in Q4 2019, closing a stake of 15 shares — an estimated $6K sold.

Paulson Wealth Management first reported a position in NVIV in Q4 2017 and held it in 7 quarters. The position peaked at $17K in Q1 2019. 12 funds tracked by Wall St. Rank hold NVIV as of Q4 2019.

  • Paulson Wealth Management reported no remaining InVivo Therapeutics Holdings Corp position as of Q4 2019 after selling out during the quarter.
  • Paulson Wealth Management sold 15 InVivo Therapeutics Holdings Corp shares in Q4 2019, an estimated $6K.
  • Paulson Wealth Management first reported a position in InVivo Therapeutics Holdings Corp in Q4 2017 and held it in 7 quarters.
  • Paulson Wealth Management's InVivo Therapeutics Holdings Corp position peaked at $17K in Q1 2019.
  • 12 funds tracked by Wall St. Rank held InVivo Therapeutics Holdings Corp as of Q4 2019.

Based on Paulson Wealth Management's 13F filing for Q4 2019, filed 21 Jan 2020.